Patient Note — 266259

progress_notes_266259_1_deid.txt

← Back to all patients Run PA Decision for this patient →

Demographics & Encounter

Patient ID266259 (PHI redacted)
Age / Gender61 / Male
Date of Service2026-04-16
ProviderNone
FacilityNone
PayerNone
ReasonNone

Diagnoses

No diagnoses extracted

Raw Note (de-identified preview)

4/16/26, 1:28 PM Print Preview [PATIENT_NAME] DOB: [DOB] (61 yo M) Acc No. [ACCOUNT_ID] DOS: 04/16/2026 Progress Notes Patient: [PATIENT_NAME] Provider: [PATIENT_NAME] Account: [ACCOUNT_ID] DOB: [DOB] Age: 61 Y Sex: Male Date: 04/16/2026 Phone: [PHONE] Address: [ADDRESS], APT 202, ALEXANDRIA, VA-[ZIP] Pcp: [PATIENT_NAME] Subjective: Chief Complaints: 1. Erectile Dysfunction. HPI: Erectile Dysfunction screening: 61yM here NPC with concern for ED. Pt is referred by Dr. [PATIENT_NAME]. He has a Hx of DM with an A1c of 6.1 on Metformin, Trulicity, lisinopril and glipizide. He is also on Flomax. He reports difficulty with both achieving and maintaining an erection. Medical History: Diabetes, High cholesterol, High blood pressure. Surgical History: knee repair . Hospitalization/Major Diagnostic Procedure: Denies Past Hospitalization. Family History: Father: deceased. Mother: deceased. Screening: Social History: Smoking: yes . Recreational drug use: no. Exercise: no. Caffeine: yes. Sexually active: yes. Medications: Taking glipiZIDE 5 MG Tablet TAKE ONE TABLET BY MOUTH TWICE A DAY Oral , Taking metFORMIN HCl 1000 MG Tablet Oral , Taking Trelegy Ellipta(Fluticasone-Umeclidin-Vilant) 200-62.5-25 MCG/ACT Aerosol Powder Breath Activated Inhalation , Taking Lisinopril 20 MG Tablet TAKE ONE TABLET BY MOUTH EVERY DAY Oral , Taking Tamsulosin HCl 0.4 MG Capsule TAKE TWO CAPSULES BY MOUTH EVERY DAY Oral , Taking Lovastatin 40 MG Tablet TAKE ONE TABLET BY MOUTH EVERY DAY WITH A MEAL Oral , Medication List reviewed and reconciled with the patient Objective: Vitals: Assessment: Assessment: 1. ED (erectile dysfunction) of non-organic origin - F52.21 (Primary) Plan: Treatment: 1. ED (erectile dysfunction) of non-organic origin LAB: Hormone Panel 2 (FSH/LH, Prolactin, Estradiol, Albumin, SHBG, Testosterone-Total) Imaging: Ultrasound : Penile Doppler Notes: He comes in today to be evaluated for erectile dysfunction. He reports difficulty with both achieving and Provider: [PATIENT_NAME] Date: 04/16/2026 1/2 4/16/26, 1:28 PM Print Preview [PATIENT_NAME] DOB: [DOB] (61 yo M) Acc No. [ACCOUNT_ID] DOS: 04/16/2026 maintaining an erection. I had a long discussion today about the physiology and pathophysiology of erectile dysfunction with him. I also discussed the utility of the penile US and how this can help assess his vasculature. He is aware he will receive an injection at the time of US to assess blood flow as well as a reversal injection to reduce his risk of a prolonged erection. Treatment options and side effects discussed include: -oral PDE5i (flushing, headaches, congestion, melanoma, visual disturbances, and priapism) -penile injection therapy (pain, bleeding, scarring at the injection site, and priapism) -penile implant surgery (bleeding, infection (1-5%), malfunction (75% working at 15 years), erosion, reservoir herniation, damage to adjacent structures, intractable pain, penile shortening, and need for the placement of semi-rigid implant). I will obtain a mornin